Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Transplantation Proceedings
|
October 1, 1994
The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines
L J Langman, R W Yatscoff
Therapeutic Drug Monitoring
|
October 1, 1994
Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines
L J Langman, R W Yatscoff
Clinical Biochemistry
|
August 29, 1998
An enzymatic method for oxalate automated using the Hitachi 911 analyzer
L J Langman, L C Allen
Critical Reviews in Clinical Laboratory Sciences
|
September 16, 1999
Homocysteine
L J Langman, D E Cole
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 8, 1999
Homocysteine: cholesterol of the 90s?
L J Langman, D E Cole
Clinical Chemistry
|
June 1, 1993
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays
R W Yatscoff, L J Langman, D F LeGatt
Clinical Biochemistry
|
November 13, 1998
Interference of IgM paraproteins in the Olympus AU800 uric acid assay
L J Langman, L C Allen, A D Romaschin
Therapeutic Drug Monitoring
|
December 1, 1994
Blood distribution of mycophenolic acid
L J Langman, D F LeGatt, R W Yatscoff
Clinical Chemistry
|
February 1, 1995
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity
L J Langman, D F LeGatt, R W Yatscoff
Clinical Pharmacology and Therapeutics
|
September 14, 2007
Translation of pharmacogenetics into clinically relevant testing modalities
L M Baudhuin, L J Langman, D J O'Kane
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Transplantation Proceedings
|
October 1, 1994
The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines
L J Langman, R W Yatscoff
Therapeutic Drug Monitoring
|
October 1, 1994
Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines
L J Langman, R W Yatscoff
Clinical Biochemistry
|
August 29, 1998
An enzymatic method for oxalate automated using the Hitachi 911 analyzer
L J Langman, L C Allen
Critical Reviews in Clinical Laboratory Sciences
|
September 16, 1999
Homocysteine
L J Langman, D E Cole
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 8, 1999
Homocysteine: cholesterol of the 90s?
L J Langman, D E Cole
Clinical Chemistry
|
June 1, 1993
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays
R W Yatscoff, L J Langman, D F LeGatt
Clinical Biochemistry
|
November 13, 1998
Interference of IgM paraproteins in the Olympus AU800 uric acid assay
L J Langman, L C Allen, A D Romaschin
Therapeutic Drug Monitoring
|
December 1, 1994
Blood distribution of mycophenolic acid
L J Langman, D F LeGatt, R W Yatscoff
Clinical Chemistry
|
February 1, 1995
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity
L J Langman, D F LeGatt, R W Yatscoff
Clinical Pharmacology and Therapeutics
|
September 14, 2007
Translation of pharmacogenetics into clinically relevant testing modalities
L M Baudhuin, L J Langman, D J O'Kane
Page
of 2